Parse Biosciences, a QIAGEN Company, Introduces FFPE-Compatible Barcoding Technology for Whole Transcriptome Single-Cell Analysis

Introduces FFPE-Compatible Barcoding Innovation Enabling Whole Transcriptome Single-Cell Analysis Parse Biosciences, a subsidiary of QIAGEN and a recognized leader in scalable single-cell sequencing technologies, has announced the commercial launch and…

Read MoreParse Biosciences, a QIAGEN Company, Introduces FFPE-Compatible Barcoding Technology for Whole Transcriptome Single-Cell Analysis